This phenotype also presents a unique somatic mutation profile to the IPMN-PDAC phenotype, containing a different set of KRAS and GNAS mutations, however due to the limited sample size of the WES data in the original cohort this somatic mutation profile cannot be generalized without further comparative analysis. Here, KRAS is linked to pancreatic intraductal papillary-mucinous neoplasm.